Deciphering the role of the histone variant macroH2A in Breast Cancer progression and iPS reprogramming

When

Mon, Sep 16, 2013 12:00 pmuntilMon, Sep 16, 2013 1:00 pm

Where

Life Sciences Building Auditorium
145 Bevier Road
Piscataway
NJ
08854

Contact

Event Actions

Other Details

Speaker
ALEXANDRE GASPAR-MAIA, PH.D.

About

Abstract

MacroH2A is an histone variant implicated in transcriptional repression. During development and differentiation, macroH2A1 and macroH2A2 isoforms become enriched in the chromatin fraction creating an epigenetic barrier to somatic cell reprogramming towards pluripotency. I therefore hypothesize that macroH2A may act as global repressor that is evicted from chromatin not only in the reprogramming process, but also during breast cancer progression. Currently, we are investigating macroH2A, H3K27me3, and H3K27ac genomic occupancy by ChIP-seq in both normal and tumorigenic cell lines to dissect the chromatin-mediated mechanisms by which loss of macroH2A renders cells more tumorigenic.